DocWire News Editors

DocwireNews

In a study, published in the European Journal of Hospital Pharmacy, researchers examined the impact of a clinical pharmacist intervention on improving the prescribing of <a href="https://www.nhlbi.nih.gov/health-topics/venous-thromboembolism#:~:text=Venous%20thromboembolism%20(VTE)%20is%20a,leg%2C%20thigh%2C%20or%20pelvis.">venous thromboembolism</a> (VTE) prophylaxis in hospitalized patients with renal impairment (RI).Researchers Dr. Naemeh Nikvarz and Dr. Zahra Seyedi, from the Faculty of Pharmacy and Pharmaceutical Sciences at the Kerman University of Medical Sciences in Kerman, Iran, observed that a clinical pharmacist using risk assessment models (RAMs) can improve the amount of VTE prophylaxis prescribed in <a href="https://www.docwirenews.com/docwire-pick/assessing-the-risk-of-vte-in-hospitalized-patients-with-acute-ischemic-stroke/">hospitalized patients</a> with RI who have a high risk of developing VTE.The study was conducted at the authors&rsquo; center&rsquo;s nephrology ward. The investigators used the Caprini RAM, Padua Prediction Score, and IMPROVE Bleeding Risk Score tools to estimate hospitalized patients&rsquo; risk for VTE and bleeding, and the rate of VTE prophylaxis administered both before and after the pharmacist&rsquo;s intervention.In their pre-intervention testing, the investigators reported that only 34.8% of high-VTE-risk patients, of which 12.5% also had a <a href="https://www.docwirenews.com/docwire-pick/cardiology-picks/relationship-between-pulmonary-embolism-severity-and-long-term-risk-of-vte-recurrence/">high bleeding risk</a>, were administered pharmacological VTE prophylaxis. Conversely, 22.2% of low-risk patients received VTE prophylaxis.After implementing the pharmacist&rsquo;s intervention, all patients with high risk&mdash;and 3.3% of low-VTE-risk patients&mdash;received VTE prophylaxis. Specifically, 7% of patients with risk of both VTE and bleeding received mechanical VTE prophylaxis while the rest received heparin.Dr. Nikvarz and Dr. Seyedi ultimately concluded that an intervention by a clinical pharmacist with implementation of the Caprini, Padua, and IMPROVE RAMs was effective for identifying the optimal patients to prescribe venous thromboembolism prophylaxis while also reducing the amount administered to low-risk patients.

MarkAlain Déry, DO

The Significant Danger Measles Pose for Unvaccinated Children

Infectious Disease

Andrew Moreno

Antithrombotic Care in Hemophilia: A Summary of Multi-Organizational Clinical Practice Guidance

Hemophilia

James Tumlin, MD

Joel M. Topf, MD, FACP

Proteinuria Remission With Sparsentan in FSGS

NKF Spring Clinical Meetings 2025

Latest News

Improved Venous Thromboembolism Prophylaxis in Renal–Impaired Patients

In a study, published in the European Journal of Hospital Pharmacy, researchers examined the impact of a clinical pharmacist intervention on improving the prescribing of ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe